Kelli Trent, MD
Internal Medicine · Lexington, KYNPI 1831417302
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,937 of the $15,944 with a category attached, or 93.7%. Organon accounts for 93.9% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $6,615 and has fallen 73.2% since, to $1,772 in 2025. Among internal medicine clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 69 payments — averaging $231.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$15K
- Pfizer$163
- Gilead$152
- GSK$151
- AbbVie$128
- Merck$70
- plus $314 from 10 others
What the payments were for
- Speaking & faculty fees$14,93794%
- Food & beverage$1,0066%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 14 | $14,965 |
| Pfizer | 11 | $163 |
| Gilead | 8 | $152 |
| GSK | 9 | $151 |
| AbbVie | 6 | $128 |
| Merck | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $53 |
| Dexcom, Inc. | 1 | $46 |
| Abbott | 2 | $36 |
| AstraZeneca | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $26 |
| Amgen | 1 | $17 |
| Cranial Technologies, Inc | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$13,167
How this compares
$15,944 in reported general payments places this provider in the 95th percentile of 1,284 internal medicine providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 25 | $34,235 |
| TrulicityDulaglutide | 15 | $12,959 |
| EliquisApixaban | 13 | $9,408 |
| Duloxetine Hcl | 13 | $732 |
| Levothyroxine Sodium | 31 | $401 |
| Wixela InhubFluticasone Propion/Salmeterol | 11 | $386 |
| Atorvastatin Calcium | 47 | $331 |
| Pravastatin Sodium | 15 | $219 |
| Pantoprazole Sodium | 15 | $208 |
| Lisinopril | 22 | $171 |
| Carvedilol | 18 | $153 |
| Gabapentin | 19 | $146 |
| Rosuvastatin Calcium | 11 | $144 |
| Buspirone Hcl | 12 | $139 |
| Escitalopram Oxalate | 14 | $135 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $53 | $12,95915 claims |
| PfizerEliquis | $163 | $9,40813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,284 internal medicine providers in Kentucky.
Other internal medicine in Lexington
- David ManninoLexington$168K
- Fadi BachaLexington$31K
- Jad BalloutLexington$30K
- Thomas von UnrugLexington$22K
- Danilo CoralesLexington$17K
- Mohamed TashaniLexington$17K
- Richard BeltLexington$14K
- Coutney SchniedersLexington$12K
- Fares KhaterWhitesburg$412K
- Bernard BuchananOwensboro$185K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.